Inventor · disambiguated record
Gary E. Borodic
Also filed as: BORODIC GARY · BORODIC GARY E
31 granted patents·30 pending applications·1,026 citations·filing 1989–2024
97Inventor score
Files withBORODIC GARY E19REVANCE THERAPEUTICS INC19BOTULINUM TOXIN RES ASS INC11ASS SYNAPSE BIOLOG4BORODIC GARY3
Top patents by PatentIndex Score
61 records- 0197US5183462AControlled administration of chemodenervating pharmaceuticalsASS SYNAPSE BIOLOG·Filed 1990·Granted Feb 2, 1993·167 cites·15 claims
- 0296US8926991B2Botulinum toxin and the treatment of primary disorders of mood and affectBORODIC GARY E·Filed 2006·Granted Jan 6, 2015·18 cites·19 claims
- 0395US7691394B2High-potency botulinum toxin formulationsBOTULINUM TOXIN RES ASS INC·Filed 2005·Granted Apr 6, 2010·33 cites·107 claims
- 0493US5696077APharmaceutical composition containing botulinum B complexASS SYNAPSE BIOLOG·Filed 1994·Granted Dec 9, 1997·161 cites·16 claims
- 0592US9901627B2Topical ocular preparation of botulinum toxin for use in ocular surface diseaseREVANCE THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·5 cites·31 claims
- 0692US8580745B2Composition for therapeutic and cosmetic botulinum toxinBORODIC GARY·Filed 2007·Granted Nov 12, 2013·9 cites·22 claims
- 0791US8192979B2Compositions, methods and devices for preparing less painful Botulinum toxin formulationsBORODIC GARY E·Filed 2005·Granted Jun 5, 2012·11 cites·21 claims
- 0891US7491403B2Pharmaceutical botulinum toxin compositionsBOTULINUM TOXIN RES ASS INC·Filed 2003·Granted Feb 17, 2009·37 cites·55 claims
- 0991US7270826B2Methods of using Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)BORODIC GARY E·Filed 2005·Granted Sep 18, 2007·9 cites·8 claims
- 1091US6429189B1Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseasesBOTULINUM TOXIN RES ASS INC·Filed 1999·Granted Aug 6, 2002·107 cites·29 claims
- 1190US5401243AControlled administration of chemodenervating pharmaceuticalsASS SYNAPSE BIOLOG·Filed 1993·Granted Mar 28, 1995·111 cites·16 claims
- 1290US5298019AControlled administration of chemodenervating pharmaceuticalsASS SYNAPSE BIOLOG·Filed 1993·Granted Mar 29, 1994·98 cites·3 claims
- 1389US9066851B2Extended length botulinum toxin formulation for human or mammalian useBORODIC GARY E·Filed 2009·Granted Jun 30, 2015·10 cites·6 claims
- 1489US8241640B2Pharmaceutical botulinum toxin compositionsBORODIC GARY·Filed 2008·Granted Aug 14, 2012·13 cites·3 claims
- 1588US8679486B2High-potency botulinum toxin formulationsBORODIC GARY E·Filed 2010·Granted Mar 25, 2014·9 cites·8 claims
- 1688US2024108700A1Methods of Treating a Spastic Disorder in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1788US2024100135A1Methods of Treating an Optic Disease in a SubjectREVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1887US2024000906A1Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1985US9950042B2Extended length botulinum toxin formulation for human or mammalian useREVANCE THERAPEUTICS INC·Filed 2015·Granted Apr 24, 2018·4 cites·17 claims
- 2084US7459164B2Composition for therapeutic and cosmetic botulinum toxinBOTULINUM TOXIN RES ASS INC·Filed 2003·Granted Dec 2, 2008·12 cites·18 claims
- 2183US11123411B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2017·Granted Sep 21, 2021·1 cites·18 claims
- 2283US7335367B2Treatment of chronic chalazion and hordeolum with botulinum toxinBOTULINUM TOXIN RES ASS INC·Filed 2004·Granted Feb 26, 2008·14 cites·25 claims
- 2381US10441641B2Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2015·Granted Oct 15, 2019·1 cites·9 claims
- 2481US8940477B2Method of detecting botulinum neurotoxin and antibodies that neutralize botulinum neurotoxin actionJOHNSON ERIC A·Filed 2008·Granted Jan 27, 2015·3 cites·16 claims
- 2581US8691769B2Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injectionsBORODIC GARY·Filed 2004·Granted Apr 8, 2014·18 cites·32 claims
- 2681US7943152B2Treatment of chronic chalazion and hordeolum with botulinum toxinBOTULINUM TOXIN RES ASSOCIATES INC·Filed 2008·Granted May 17, 2011·6 cites·14 claims
- 2779US2020078450A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2877US9393291B2Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory bedsBORODIC GARY E·Filed 2013·Granted Jul 19, 2016·1 cites·18 claims
- 2977US2021308236A1Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3076US5053005AChemomodulation of curvature of the juvenile spineBORODIC GARY E·Filed 1989·Granted Oct 1, 1991·137 cites·7 claims
- 3176US2021252116A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3276US2021283228A1Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3375US2015086533A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectBOTULINUM TOXIN RES ASS INC·Filed 2014·Application pending·0 cites
- 3475US2017143807A9Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3573US2024189402A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2024·Application pending·0 cites
- 3672US7670608B2Selection of patients with increased responsiveness to botulinum toxinBOTULINUM TOXIN RES ASS INC·Filed 2004·Granted Mar 2, 2010·2 cites·10 claims
- 3770US7537773B1Chemodenervating pharmaceutical as anti-inflammatory agentBOTULINUM TOXIN RES ASS INC·Filed 1999·Granted May 26, 2009·29 cites·24 claims
- 3870US2009148476A1Chemodenervating pharmaceutical as anti-inflammatory agentBORODIC GARY E·Filed 2008·Application pending·0 cites
- 3969US2017165331A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4069US2017165330A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4167US2017333537A9Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4266US2023390368A1Methods of Treating Cervical Dystonia in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4365US11123412B2Method of treating macular degeneration using botulinum toxin-based pharmaceuticalsBORODIC GARY E·Filed 2018·Granted Sep 21, 2021·0 cites·10 claims
- 4465US2015297688A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectBOTULINUM TOXIN RES ASS INC·Filed 2015·Application pending·0 cites
- 4565US2015258183A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectBOTULINUM TOXIN RES ASS INC·Filed 2015·Application pending·0 cites
- 4664US2010278867A1Use of botulinum toxin for the treatment of chronic facial painBORODIC GARY E·Filed 2006·Application pending·0 cites
- 4761US2020368331A1Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based PharmaceuticalsBORODIC GARY E·Filed 2020·Application pending·0 cites
- 4859US10857215B2Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory bedsREVANCE THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2020·0 cites·29 claims
- 4958US2014315820A1High-Potency Botulinum Toxin FormulationsBORODIC GARY E·Filed 2014·Application pending·0 cites
- 5056US2002187164A1Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseasesFiled 2002·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →